Evidence map›Paper›PMID 38125886›Full record

ArticleFrontiers in pharmacology2023

Preparation and investigation of a novel combination of

Hamid Saeed Shah, Sumera Zaib, Imtiaz Khan, Mahmoud A Sliem, Osama Alharbi, Mohammed Al-Ghorbani, Zobia Jawad, Kiran Shahzadi, Sajjad Awan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Hamid Saeed ShahInstitute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan.
Sumera ZaibDepartment of Basic and Applied Chemistry, Faculty of Science and Technology, University of Central Punjab, Lahore, Pakistan.
Imtiaz KhanDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, Manchester, United Kingdom.
Mahmoud A SliemDepartment of Chemistry, Faculty of Science, Taibah University, Medinah, Saudi Arabia.
Osama AlharbiDepartment of Chemistry, Faculty of Science, Taibah University, Medinah, Saudi Arabia.
Mohammed Al-GhorbaniDepartment of Chemistry, Faculty of Science, Taibah University, Medinah, Saudi Arabia.
Zobia JawadLadywillingdon Hospital, King Edward Medical University, Lahore, Pakistan.
Kiran ShahzadiDepartment of Basic and Applied Chemistry, Faculty of Science and Technology, University of Central Punjab, Lahore, Pakistan.
Sajjad AwanCollege of Pharmacy, University of Sargodha, Sargodha, Pakistan.
Taibah University · SAUniversity of Central Punjab · PKKing Edward Medical University · PKUniversity of Manchester · GBUniversity of Sargodha · PKUniversity of Veterinary and Animal Sciences · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancerflow cytometrynanospongesSolanum nigrumβ-cyclodextrin

Identifiers

PMID38125886
PMCPMC10730681
OpenAlexW4389393435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.